Sree Mandavilli

Sree Ram Mandavilli currently serves as the Subsidiary Plant Finance Head at Dr. Reddy's Laboratories in Shreveport, LA, where he plays a pivotal role in shaping the financial strategy and operational efficiency of the manufacturing facility. With over a decade of specialized experience in pharmaceutical finance, Sree Ram brings a comprehensive understanding of business planning, budgeting, and financial analysis, ensuring that the subsidiary aligns with corporate objectives while maintaining compliance with industry standards and GAAP. His leadership in financial controlling encompasses overseeing budgeting processes, preparing detailed MIS reports—including profit & loss statements, sales variance analysis, and operating expense reviews—and providing actionable insights that support profitability enhancement and cost optimization.

In his current role, Sree Ram has spearheaded key projects focused on financial forecasting, inventory valuation, and quarterly balance sheet management, enabling the management team to make informed strategic decisions. His expertise in internal controls and auditing ensures robust financial governance, mitigating risks and safeguarding assets. Additionally, his proficiency in accounts payable operations and GL controlling has contributed to streamlined financial workflows and improved cash flow management.

Sree Ram’s ability to analyze complex financial data and translate it into clear, strategic recommendations has been instrumental in driving operational excellence at the Shreveport plant. His skills in business analysis and reporting not only support day-to-day decision-making but also facilitate long-term planning and sustainable growth. As a leader, he fosters a culture of financial discipline and continuous improvement, ensuring the subsidiary’s financial health aligns with Dr. Reddy’s Laboratories’ global standards and strategic vision.